romiplostim
kyowa kirin,amgen
['mds', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'romiplostim']
dr uwe platzbecker presenting on behalf of dr on value of romiplostim for thrombocytopenia in low risk #mdssm with 42% hi-p/low risk of #amlsm progression but didn t meet primary ep of validating predictive model (based on epo level &amp; plt transfusion burden) #eha2022 
Director-Heme Early Therapeutics & Leader-Leukemia/Myeloid Research @Yale. Personal views. I tweet on cancer, travel, food & soccer. COI: https://t.co/6XkF8CmtrK